Condition

Chronic Heart Failure With Preserved Ejection Fraction

ClinicalTrials.gov condition label

Clinical trials2

Recruiting0

Common interventions5

Lead sponsors shown2

Clinical trials

2 shown

Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection FractionNCT04944706 · 2021-07-27

COMPLETED

Patient-reported Outcomes in Vericiguat-treated Patients With HFpEFNCT03547583 · 2018-06-15

COMPLETED

Common interventions

PlaceboDRUG1Qishen Yiqi dripping pills 2 bags/time + Qishen Yiqi dripping pills placebo 2 bags/timeDRUG1Qishen Yiqi dripping pills 4 bags/timeDRUG1Qishen Yiqi dripping pills placebo 4 bags/timeDRUG1Vericiguat (BAY1021189) 2.5 mg, 5 mg or 10 mg IR tabletsDRUG1

Leading sponsors

Bayer1Tasly Pharmaceutical Group Co., Ltd1

Trial status mix

COMPLETED2

Phase mix

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.